After it completes its $66 billion acquisition of Monsanto, Bayer may attempt to eliminate the stigma associated with Monsanto by simply changing the name, reports Bloomberg.
According to Bloomberg sources, the German drug and chemical giant seeks to avoid damaging its own reputation as it links up with the seed and chemical company known for making Agent Orange and GMO crops.
In a recent interview with Bloomberg TV, Monsanto CEO Hugh Grant seemed open to the idea when he said, “The key is less about the name and more about the products developed.”
Read the Bloomberg coverage